Isa Iber VD
A Phase 1b/2 Study of the Combination Isatuximab, Iberdomide, Bortezomib, and Dexamethasone in Newly Diagnosed Multiple Myeloma Who Are Transplant Ineligible or Not Intended for Upfront Transplant
Arms / Cohorts
Experimental:Arm B: Age ≥70 and/or Intermediate Fit/Frail (Reduced-intensity Schedule)
Not yet accepting
Experimental:Arm A: <70 and Fit (Standard-intensity Schedule)
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.